Osteoarthritis year 2012 in review: Biomarkers

Osteoarthritis and Cartilage

Volumn 20, Issue 12, 2012, Pages 1451-1464

  Mobasheri, A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adipokines; Articular cartilage; Biochemical marker; Biomarker; Chemotactic proteins; Complement; Inflammation; Osteoarthritis; Proteomics; Synovium

Indexed keywords

BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CORTICOSTEROID; EPITOPE; FIBULIN; FIBULIN 3 PEPTIDE 1; FIBULIN 3 PEPTIDE 2; FOLLISTATIN; FOLLISTATIN LIKE PROTEIN 1; HYALURONIC ACID; UNCLASSIFIED DRUG;

BODY FLUID; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; RADIOIMMUNOASSAY; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CARTILAGE; CHONDROCYTES; DISEASE PROGRESSION; HUMANS; OSTEOARTHRITIS; PROTEOMICS; SYNOVIAL FLUID;

EID: 84867868437     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.07.009     Document Type: Review

References (75)

1. Juni P., Reichenbach S., Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 2006, 20:721-740.
2. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Clin Geriatr Med 2010, 26:355-369.
3. Rai M.F., Sandell L.J. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr 2011, 21:131-142.
4. Yusuf E., Nelissen R.G., Ioan-Facsinay A., Stojanovic-Susulic V., DeGroot J., van Osch G., et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010, 69:761-765.
5. Lohmander L.S., Roos E.M. Clinical update: treating osteoarthritis. Lancet 2007, 370:2082-2084.
6. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
7. Kraus V.B., Burnett B., Coindreau J., Cottrell S., Eyre D., Gendreau M., et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 2011, 19:515-542.
8. Qvist P., Bay-Jensen A.C., Christiansen C., Dam E.B., Pastoureau P., Karsdal M.A. The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?. Pharmacol Res 2008, 58:1-7.
9. Patra D., Sandell L.J. Evolving biomarkers in osteoarthritis. J Knee Surg 2011, 24:241-249.
10. Naba A., Clauser K.R., Hoersch S., Liu H., Carr S.A., Hynes R.O. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 2012, 11. M111.014647. Epub 2011 Dec 9.
11. Hynes R.O., Naba A. Overview of the matrisome - an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol 2012, 4:a004903.
12. Kraus V.B. Osteoarthritis year 2010 in review: biochemical markers. Osteoarthritis Cartilage 2011, 19:346-353.
13. Henrotin Y. Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis Cartilage 2012, 20:215-217.
14. van Spil W.E., Jansen N.W., Bijlsma J.W., Reijman M., Degroot J., Welsing P.M., et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage 2012, 20:745-754.
15. Willett T.L., Kandel R., De Croos J.N., Avery N.C., Grynpas M.D. Enhanced levels of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression. Osteoarthritis Cartilage 2012, 20:736-744.
16. Braza-Boils A., Ferrandiz M.L., Terencio M.C., Alcaraz M.J. Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis. Exp Gerontol 2012, 47:406-409.
17. Alam M.R., Ji J.R., Kim M.S., Kim N.S. Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogs. J Vet Sci 2011, 12:273-280.
18. Garner B.C., Stoker A.M., Kuroki K., Evans R., Cook C.R., Cook J.L. Using animal models in osteoarthritis biomarker research. J Knee Surg 2011, 24:251-264.
19. Streich N.A., Zimmermann D., Schmitt H., Bode G. Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency. Int Orthop 2011, 35:1633-1637.
20. Gonzalez-Alvaro I., Ortiz A.M., Alvaro-Gracia J.M., Castaneda S., Diaz-Sanchez B., Carvajal I., et al. Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis. PLoS One 2011, 6:e29492.
21. Cattano N.M., Driban J.B., Balasubramanian E., Barbe M.F., Amin M., Sitler M.R. Biochemical comparison of osteoarthritic knees with and without effusion. BMC Musculoskelet Disord 2011, 12:273.
22. Conrozier T., Balblanc J.C., Richette P., Mulleman D., Maillet B., Henrotin Y., et al. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res 2012, 30:679-685.
23. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14:1431-1437.
24. Duan Y., Hao D., Li M., Wu Z., Li D., Yang X., et al. Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol Int 2012, 32:985-990.
25. Hao D., Li M., Wu Z., Duan Y., Li D., Qiu G. Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis. Rheumatol Int 2011, 31:1433-1437.
26. Xu L., Zhu G.B., Wang L., Wang D.F., Jiang X.R. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012, 60:583-586.
27. Song S.Y., Han Y.D., Hong S.Y., Kim K., Yang S.S., Min B.H., et al. Chip-based cartilage oligomeric matrix protein detection in serum and synovial fluid for osteoarthritis diagnosis. Anal Biochem 2012, 420:139-146.
28. Argraves W.S., Greene L.M., Cooley M.A., Gallagher W.M. Fibulins: physiological and disease perspectives. EMBO Rep 2003, 4:1127-1131.
29. Argraves W.S., Tran H., Burgess W.H., Dickerson K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990, 111:3155-3164.
30. Henrotin Y., Gharbi M., Mazzucchelli G., Dubuc J.E., De Pauw E., Deberg M. Fibulin-3 peptides (Fib3-1 and Fib3-2) are potential biomarkers of osteoarthritis. Arthritis Rheum 2012, 64:2260-2267.
31. Wang Y., Li D., Xu N., Tao W., Zhu R., Sun R., et al. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis. Arthritis Res Ther 2011, 13:R193.
32. Murakami K., Tanaka M., Usui T., Kawabata D., Shiomi A., Iguchi-Hashimoto M., et al. Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett 2012, 586:319-324.
33. Li D., Wang Y., Xu N., Wei Q., Wu M., Li X., et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Res Ther 2011, 13:R17.
34. Tanaka M., Ozaki S., Osakada F., Mori K., Okubo M., Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol 1998, 10:1305-1314.
35. Ehara Y., Sakurai D., Tsuchiya N., Nakano K., Tanaka Y., Yamaguchi A., et al. Follistatin-related protein gene (FRP) is expressed in the synovial tissues of rheumatoid arthritis, but its polymorphisms are not associated with genetic susceptibility. Clin Exp Rheumatol 2004, 22:707-712.
36. Clutter S.D., Wilson D.C., Marinov A.D., Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol 2009, 182:234-239.
37. Muller-Eberhard H.J. The membrane attack complex of complement. Annu Rev Immunol 1986, 4:503-528.
38. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
39. Satsuma S., Scudamore R.A., Cooke T.D., Aston W.P., Saura R. Toxicity of complement for chondrocytes. A possible source of cartilage degradation in inflammatory arthritis. Rheumatol Int 1993, 13:71-75.
40. Daniels R.H., Williams B.D., Morgan B.P. Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation. Immunology 1990, 71:312-316.
41. Okroj M., Heinegard D., Holmdahl R., Blom A.M. Rheumatoid arthritis and the complement system. Ann Med 2007, 39:517-530.
42. Alomari W.R., Archer J.R., Brocklehurst R., Currey H.L. Binding of immunoglobulins and immune complexes to cartilage derived extracts. Clin Exp Immunol 1983, 54:716-722.
43. Low J.M., Moore T.L. A role for the complement system in rheumatoid arthritis. Curr Pharm Des 2005, 11:655-670.
44. Robinson N.E., Robinson A.B. Deamidation of human proteins. Proc Natl Acad Sci U S A 2001, 98:12409-12413.
45. Robinson N.E. Protein deamidation. Proc Natl Acad Sci U S A 2002, 99:5283-5288.
46. Catterall J.B., Hsueh M.F., Stabler T.V., McCudden C.R., Bolognesi M., Zura R., et al. Protein modification by deamidation indicates variations in joint extracellular matrix turnover. J Biol Chem 2012, 287:4640-4651.
47. Jordan J.M., Linder G.F., Renner J.B., Fryer J.G. The impact of arthritis in rural populations. Arthritis Care Res 1995, 8:242-250.
48. Clark A.G., Jordan J.M., Vilim V., Renner J.B., Dragomir A.D., Luta G., et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 1999, 42:2356-2364.
49. Dragomir A.D., Kraus V.B., Renner J.B., Luta G., Clark A., Vilim V., et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2002, 10:687-691.
50. Jordan J.M., Luta G., Stabler T., Renner J.B., Dragomir A.D., Vilim V., et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum 2003, 48:675-681.
51. Mateos J., Lourido L., Fernandez-Puente P., Calamia V., Fernandez-Lopez C., Oreiro N., et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics 2012, 75:2869-2878.
52. Kriegsmann M., Seeley E., Schwarting A., Kriegsmann J., Otto M., Thabe H., et al. MALDI MS imaging as a powerful tool for investigating synovial tissue. Scand J Rheumatol 2012, 41:305-309.
53. Bay-Jensen A.C., Sondergaard B.C., Christiansen C., Karsdal M.A., Madsen S.H., Qvist P. Biochemical markers of joint tissue turnover. Assay Drug Dev Technol 2010, 8:118-124.
54. Qvist P., Christiansen C., Karsdal M.A., Madsen S.H., Sondergaard B.C., Bay-Jensen A.C. Application of biochemical markers in development of drugs for treatment of osteoarthritis. Biomarkers 2010, 15:1-19.
55. Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006, 14:723-727.
56. Williams F.M. Biomarkers: in combination they may do better. Arthritis Res Ther 2009, 11:130.
57. Weng X., Liao Q., Li K., Li Y., Mi M., Zhong D. Screening serum biomarker of knee osteoarthritis using a phage display technique. Clin Biochem 2012, 45:303-308.
58. Martinez-Sanchez A., Dudek K.A., Murphy C.L. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem 2012, 287:916-924.
59. Saetan N., Honsawek S., Tanavalee A., Tantavisut S., Yuktanandana P., Parkpian V. Association of plasma and synovial fluid interferon-gamma inducible protein-10 with radiographic severity in knee osteoarthritis. Clin Biochem 2011, 44:1218-1222.
60. Vincourt J.B., Etienne S., Grossin L., Cottet J., Bantsimba-Malanda C., Netter P., et al. Matrilin-3 switches from anti- to pro-anabolic upon integration to the extracellular matrix. Matrix Biol 2012, 31:290-298.
61. Onnerfjord P., Khabut A., Reinholt F.P., Svensson O., Heinegard D. Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups. J Biol Chem 2012, 287:18913-18924.
62. Sun S., Fang K., Zhao Y., Yan X., Chang X. Increased expression of alpha 1-anti-trypsin in the synovial tissues of patients with ankylosing spondylitis. Clin Exp Rheumatol 2012, 30:39-44.
63. Chiaradia E., Pepe M., Tartaglia M., Scoppetta F., D'Ambrosio C., Renzone G., et al. Gambling on putative biomarkers of osteoarthritis and osteochondrosis by equine synovial fluid proteomics. J Proteomics 2012, 75:4478-4493.
64. Katano M., Okamoto K., Suematsu N., Kurokawa M.S., Nakamura H., Masuko K., et al. Increased expression of S100 calcium binding protein A8 in GM-CSF-stimulated neutrophils leads to the increased expressions of IL-8 and IL-16. Clin Exp Rheumatol 2011, 29:768-775.
65. Pan X., Huang L., Chen J., Dai Y., Chen X. Analysis of synovial fluid in knee joint of osteoarthritis: 5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Int Orthop 2012, 36:57-64.
66. Fernandez-Puente P., Mateos J., Fernandez-Costa C., Oreiro N., Fernandez-Lopez C., Ruiz-Romero C., et al. Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 2011, 10:5095-5101.
67. Rousseau J.C., Garnero P. Biological markers in osteoarthritis. Bone 2012, 51:265-277.
68. Patra D., Sandell L.J. Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol 2011, 23:465-470.
69. van der Kraan P.M., van den Berg W.B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthritis Cartilage 2012, 20:223-232.
70. Hoch J.M., Mattacola C.G., Medina McKeon J.M., Howard J.S., Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2011, 19:1396-1404.
71. Madry H., Luyten F.P., Facchini A. Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2012, 20:407-422.
72. Claessen K.M., Ramautar S.R., Pereira A.M., Smit J.W., Biermasz N.R., Kloppenburg M. Relationship between insulin-like growth factor-1 and radiographic disease in patients with primary osteoarthritis: a systematic review. Osteoarthritis Cartilage 2012, 20:79-86.
73. Gharbi M., Deberg M., Henrotin Y. Application for proteomic techniques in studying osteoarthritis: a review. Front Physiol 2011, 2:90.
74. Mobasheri A. Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging. Front Physiol 2011, 2:108.
75. Heinegard D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011, 7:50-56.